Summary
This article presents initial data from A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin [REVERSE; NCT01143246], the largest trial to date in type 1 hepatorenal syndrome using terlipressin.
- Hepatorenal Syndrome
- Hepatology Clinical Trials
- Liver Conditions
- Hepatorenal Syndrome
- Hepatology Clinical Trials
- Liver Conditions
- Hepatology
- © 2014 MD Conference Express®
Tools
Terlipressin and Albumin Combination Therapy Improves Renal Function in HRS-1
Permalink:
Table of contents
Cited By...
- No citing articles found.